Genomic characterization of malignant pleural mesothelioma and associated clinical outcomes by Paul Markowitz, Malini Patel, Roman Groisberg, Joseph Aisner, Salma K. Jabbour, Subhajyoti De, Shridar Ganesan, Jyoti Malhotra

Subjects: Get full text

Quantified pathway mutations associate epithelial-mesenchymal transition and immune escape with poor prognosis and immunotherapy resistance of head and neck squamous cell carcinoma by Yuhong Huang, Han Liu, Bo Liu, Xiaoyan Chen, Danya Li, Junyuan Xue, Nan Li, Lei Zhu, Liu Yang, Jing Xiao, Chao Liu

Subjects: “…Pathway Mutation Burden (PMB)…”
Get full text

Angiosarcoma of the scalp successfully treated with Nivolumab—A case report by Casandra A. Coltoiu, Marie Piroth, Julia Bonnelye, Ute Zimmermann, Gaëlle Quereux

Subjects: Get full text

Research Progress on Heterogeneity of Tumor Mutation Burden in Patients with 
Non-small Cell Lung Cancer by Abdurazik MIHRAY, Peng CHEN

Subjects: Get full text

Tumor immunogenomic signatures improve a prognostic model of melanoma survival by Leah Morales, Danny Simpson, Robert Ferguson, John Cadley, Eduardo Esteva, Kelsey Monson, Vylyny Chat, Carlos Martinez, Jeffrey Weber, Iman Osman, Tomas Kirchhoff

Subjects: Get full text

Solar elastosis correlates with high tumor mutation burden and better 5-year disease-specific survival in patients with stage II/III melanoma by Cecilia Lezcano, Li Luo, Ronglai Shen, Irene Orlow, Nancy E. Thomas, Marianne Berwick, Klaus J. Busam

Subjects: Get full text

Identification of novel candidate risk genes for myelomeningocele within the glucose homeostasis/oxidative stress and folate/one‐carbon metabolism networks by Paul Hillman, Craig Baker, Luke Hebert, Michael Brown, James Hixson, Allison Ashley‐Koch, Alanna C. Morrison, Hope Northrup, Kit Sing Au

Subjects: Get full text

Integrating POLE/POLD1 mutated for immunotherapy treatment planning of advanced stage non‐small cell lung cancer by Shuhua Zheng, Yenong Cao, James Randall, Haomin Yu, Tarita O. Thomas

Subjects: Get full text

High tumor mutation burden predicts better efficacy of immunotherapy: a pooled analysis of 103078 cancer patients by Dedong Cao, Huilin Xu, Ximing Xu, Tao Guo, Wei Ge

Subjects: “…tumor mutation burden…”
Get full text

BLM mutation is associated with increased tumor mutation burden and improved survival after immunotherapy across multiple cancers by Huiping Shi, Liang Gao, Hong Yin, Min Jiang

Subjects: Get full text

Prognostic Value and Therapeutic Perspectives of CXCR Members in the Glioma Microenvironment by Jiarong He, Zhongzhong Jiang, Jiawei Lei, Wen Zhou, Yan Cui, Biao Luo, Mingming Zhang

Subjects: Get full text

The PARPscore system using poly (ADP-ribose) polymerase (PARP) family features and tumor immune microenvironment in glioma by Cheng Zhang, Juan Feng, Xia Zhou, Jie Zhang, Chuming Tao, Hongwei Zhou

Subjects: Get full text

STING signalling compensates for low tumour mutation burden to drive anti-tumour immunityResearch in context by Jiayi Tan, Colt A. Egelston, Weihua Guo, Jeremy M. Stark, Peter P. Lee

Subjects: “…Tumour mutation burden…”
Get full text

Exploring the prognostic function of TMB-related prognostic signature in patients with colon cancer by Yan Zhao, Xiaolong Liang, Xudong Duan, Chengli Zhang

Subjects: “…Tumor mutation burden…”
Get full text

Identification and Comprehensive Prognostic Analysis of a Novel Chemokine-Related lncRNA Signature and Immune Landscape in Gastric Cancer by Xiaolong Liang, Gangfeng Yu, Lang Zha, Xiong Guo, Anqi Cheng, Chuan Qin, Chuan Qin, Han Zhang, Ziwei Wang

Subjects: Get full text

Identification and Development of Subtypes with Poor Prognosis in Gastric Cancer Based on Both Hypoxia and Immune Cell Infiltration by Wang Y, Sun J, Yang Y, Zebaze Dongmo S, Qian Y, Wang Z

Subjects: Get full text

High tumor mutation burden (TMB) in microsatellite stable (MSS) colorectal cancers: Diverse molecular associations point to variable pathophysiology by Ioannis A. Voutsadakis

Subjects: Get full text

A Prognostic Model of 15 Immune-Related Gene Pairs Associated With Tumor Mutation Burden for Hepatocellular Carcinoma by Junyu Huo, Liqun Wu, Yunjin Zang

Subjects: Get full text

Urothelial Bladder Carcinomas with High Tumor Mutation Burden Have a Better Prognosis and Targetable Molecular Defects beyond Immunotherapies by Ioannis A. Voutsadakis

Subjects: Get full text

Age-related mutational signature negatively associated with immune activity and survival outcome in triple-negative breast cancer by Hao Chen, Wei Chong, Xiaorong Yang, Yuan Zhang, Shaowei Sang, Xiangchun Li, Ming Lu

Subjects: Get full text